Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology CongressPRNewsWire • 09/10/22
Exact Sciences (EXAS) Down 25.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/01/22
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/02/22
Exact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer PatientsPRNewsWire • 08/02/22
Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening PolicyPRNewsWire • 07/08/22
Exact Sciences (EXAS) Surges 6.9%: Is This an Indication of Further Gains?Zacks Investment Research • 06/27/22
Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costsPRNewsWire • 06/21/22
Exact Sciences Showcases Breadth of Early Detection and Treatment Guidance Portfolio with Multiple Data Presentations at ASCO 2022PRNewsWire • 05/27/22